BIONET Corp. (TPEX:1784)
Taiwan · Delayed Price · Currency is TWD 59.40
-0.70 (-1.16%)
Sep 8, 2026, 1:30 PM CST
BIONET Market Cap
BIONET has a market cap or net worth of 2.96 billion as of September 8, 2026. Its market cap has decreased by -29.11% in one year.
Market Cap
2.96B
Enterprise Value
2.61B
Revenue
1.29B
Ranking
n/a
PE Ratio
52.20
Stock Price
59.40
ChartMarket Cap Chart
Since November 3, 2008, BIONET's market cap has increased from 1.14B to 2.96B, an increase of 158.83%. That is a compound annual growth rate of 5.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 2.96B | -43.15% |
| Dec 31, 2025 | 5.21B | 29.12% |
| Dec 31, 2024 | 4.03B | 47.30% |
| Dec 29, 2023 | 2.74B | 32.70% |
| Dec 30, 2022 | 2.06B | 9.73% |
| Dec 30, 2021 | 1.88B | -2.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| DIVA Laboratories | 1.88B |
| Genetics Generation Advancement | 1.06B |
| Puriblood Medical | 1.03B |
| Kim Forest Enterprise | 736.68M |
| Sofiva Genomics | 732.02M |
| TFBS Bioscience | 667.34M |
| Welgene Biotech | 379.86M |
| Pharmigene | 352.75M |